Previous Page  56 / 65 Next Page
Information
Show Menu
Previous Page 56 / 65 Next Page
Page Background

Page 80

May 24-25, 2018

London, UK

Vascular Surgery 2018

3

rd

Edition of World Congress & Exhibition on

Vascular Surgery

Journal of Vascular and Endovascular Therapy

ISSN: 2573-4482

Purpose:

To evaluate the safety and efficacy of hybrid repair for

aortic lesions involving aortic arch.

Materials & Methods:

From February 2009 to September 2016,

81 consecutive patients (70men; mean age 63.4±7.9 years, range

32-79) underwent brachiocephalic bypass combined with stent-

graft implantation (hybrid) and were enrolled in the study. Aortic

pathologies included Stanford type B aortic dissection (n=22),

aortic arch aneurysm (n=26), aortic arch pseudoaneurysm (n=14),

aortic arch penetrating ulcer (n=11) and proximal endoleak (n=5)

or pseudoaneurysm formation (n=3) after thoracic endovascular

aortic repair (TEVAR). Hybrid repair comprised 3 landing in zone

0, 44 landing in zone 1 and 34 landing in zone 2. Simultaneous

procedures included left subclavian artery embolization (n=57),

endovascular abdominal aortic repair (n=1), coronary artery

bypass (n=1), left commoncarotidendarterectomy (n=1) and renal

stenting (n=4). Follow-up was performed at 1 month, 3 months, 6

months, 1 year and annually thereafter to investigate endoleak,

patency of vascular graft and exclusion of aortic pathology.

Results:

Technical success was 100%. Instant endoleak was

observed in 9 (11.1%, 7 type Ⅰ, 2 type Ⅱ) cases on postoperative

angiography. Perioperative complications included iatrogenic

ascending aortic dissection (n=1, 1.2%), stroke (n=2, 2.5%),

anastomotic bleeding (n=1, 1.2%), both lower limbs thrombosis

(n=1, 1.2%) and acute respiratory failure (n=2, 2.5%). Early

morbidity was 8.6% (7/81). Early death occurred in 5 cases (6.2%)

due to stroke, anastomotic bleeding, acute respiratory failure and

sudden death. Follow-up was complete in 100% for 39.4±14.5

months (range 1-81 months). During follow-up, all the vascular

grafts were patent. The overall endoleak rate was 13.58% (11/81).

Late mortality was 6.2% (5/81) and morbidity was 14.5% (8/81).

Conclusions:

Hybrid repair of aortic pathologies involving aortic

arch is safe and effective with good short and mid-term results,

greatly expanding the indication of endovascular aortic repair.

Recent Publications

1. Xydas S, Mihos C G, Williams R F, et al. (2017) Hybrid

repair of aortic arch aneurysms: a comprehensive

review. J Thorac Dis, 9(Suppl 7):S629-S634.

2. Tadros R, Safir S R, Faries P L, et al. (2017) Hybrid repair

techniques for complex aneurysms and dissections

involving the aortic arch and thoracic aorta. SurgTechnol

Int, 30:243-247.

3. Pagliariccio G and Gatta E (2017) Rupture of a complex

aortic arch aneurysm: hybrid repair. Eur J Vasc Endovasc

Surg, 54(3):330.

4. Arnaoutakis G J and Szeto W Y (2016) Hybrid aortic arch

repair: The ultimate solution or a stop along the way

to a total endovascular arch reconstruction? J Thorac

Cardiovasc Surg, 152(1):169-170.

5. Faure E M, Canaud L, Marty Ane C, et al. (2016) Hybrid

aortic arch repair for dissecting aneurysm. J Thorac

Cardiovasc Surg, 152(1):162-168.

Biography

Yu Guo Xue is specialized on the diagnosis and interventional treatment

of aortic diseases, including dissection, intramural hematoma, penetrating

aortic ulcer, aneurysm, pseudoaneurysm and coarctation. Every year, more

than 300 patients with aortic diseases underwent endovascular treatment

at Beijing aortic diseases center.

xueyuguo2006@163.com

Hybrid repair of aortic pathology involving aortic arch

Yu Guo Xue, Li Zhong Sun, Jun Zheng, Shangdong Xu

and

Lian Jun Huang

Beijing Aortic Diseases Center, China

Yu Guo Xue et al., J Vasc Endovasc Therapy 2018, Volume 3

DOI: 10.21767/2573-4482-C1-002